17.5 Headaches
Cranial causes
Migraine
Epidemiological features
• the commonest cause of recurrent headaches
• showing increasing prevalence. In a 1974 Finnish study using rigid criteria, 1.9% of 7-year-old children suffered from migraine headaches. In 1992 the study was repeated with the same criteria and the prevalence had increased to 5.7%.
• more common with increasing age of the child
• more common in males before puberty but in females after puberty
• a leading cause of referrals to paediatricians and child neurologists.
Types of migraine
• Unexplained attacks of vomiting, without associated headache, may also be precursors of migraine. These attacks can be very puzzling diagnostically and often very debilitating, possibly recurring after a predictable interval and sometimes requiring intravenous fluids and hospitalization. With the passage of time, headaches may become more of a feature of these attacks, which are labelled ‘cyclical vomiting’.
• Recurring episodes of unexplained abdominal pain defying diagnosis despite multiple investigations can also be very debilitating. There may be a family history of migraine and as time goes by the child’s pain, known as ‘abdominal migraine’ may become associated with and eventually replaced by migraine headaches.
• In early childhood, usually before the age of 5 years, patients may experience recurrent episodes of sudden onset of true vertigo. These are extremely distressing and cause the child to seek a cuddle, or lie on the ground to relieve the feeling of spinning. These events last a few minutes, sometimes hours, and may be associated with pallor, nausea and vomiting, and possibly nystagmus. In some studies up to 80% of these children, who are described as having ‘benign paroxysmal vertigo’, subsequently develop migraine headaches.
Aetiology
• intercurrent systemic infections, particularly with fever
• worry and stress, either domestic, social or educational in origin. While these factors remain, they may greatly complicate treatment. The distinction from ‘stress’ or ‘tension’ headaches without an underlying migraine basis may be very difficult
• foodstuffs. This is a very controversial area, with evidence for and against. Citrus fruit, cheese, chocolate and processed meat have been implicated
• food additives, such as monosodium glutamate, sodium nitrite, benzoic acid, tartrazine.
Treatment
Treatment can be divided into the following tiers:
Nevertheless, the following medications are commonly used in clinical practice:
• Cyproheptadine, an antihistamine with serotonin-blocking and calcium channel-blocking properties. Side-effects include drowsiness (which may be minimized with a single night-time dose regimen) and increased appetite. Effective doses range from 0.1–0.3 mg per kg per day, given either once or twice daily.
• Propranolol, a β-adrenergic blocking drug, also blocks release of serotonin from platelets. It is contraindicated in asthma. Doses range from 0.5 to 2.0 mg per kg per day in two or three equal doses. The value of propranolol and similar drugs has been proven in adults, but trials in children have produced conflicting results.
• Pizotifen, with antiserotonin and antihistamine properties, has side-effects of increased appetite, weight gain and drowsiness. The last may be avoided by a single night-time dose. Doses are limited by the single-size pill format (0.5 mg) but range from one to three at night.
• Clonidine, a vasoactive drug, has been trialled in a range of conditions in children but lacks good evidence for use in migraine and has significant potential side-effects.
• Amitriptyline, originally marketed as an antidepressant, has been used for migraine prophylaxis in children. It may be particularly useful where there are stress and depressive features, but care must be taken to avoid provoking cardiac arrhythmias.